en.Wedoany.com Reported - Guangzhou Atom High-Tech Isotope Pharmaceutical Co., Ltd. recently exchanged views with the Guangdong Radiation Protection Association on the development of a group standard for the automated dispensing of fluorine-18 radionuclide drugs, clarifying the key points and details of the standard formulation.

On June 11, Liu Xiaobing, General Manager of Guangzhou Atom High-Tech Isotope Pharmaceutical Co., Ltd., led personnel from the Safety Department, Production Department, and Technology Department to visit the Guangdong Radiation Protection Association. Association President Kong Lingfeng welcomed the delegation and acknowledged the company's achievements and contributions in the field of nuclear medicine.

During the discussions, both parties conducted in-depth deliberations on the group standard related to the automated dispensing of fluorine-18 radionuclide drugs, covering core technical points such as technical guidelines, automated dispensing technical requirements, on-site safety production management, and radioactive waste disposal and monitoring. This further clarified the priorities and details in the standard formulation process.

Both sides agreed that establishing a group standard for the automated dispensing of fluorine-18 radionuclide drugs is of great significance for standardizing the production processes of nuclear pharmaceutical companies and strengthening nuclear and radiation safety defenses. The association will leverage its platform advantages to collaborate with Guangzhou Atom High-Tech Isotope Pharmaceutical Co., Ltd. in advancing the project initiation of this group standard, promoting the standardized and high-quality development of Guangdong's nuclear medicine industry through standardization efforts.

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com